-
-
-
-
-
-
-
H.C. Wainwright Starts Dova Pharmaceuticals Inc (DOVA) at Buy
-
-
-
-
-
-
-
Dova Pharmaceuticals Reports First Quarter 2018 Operating and Financial Results
-
-
-
-
-
-
-
Dova Pharmaceuticals (DOVA) Prices 2.5M Share Common Offering at $32/Sh
-
-
-
-
-
-
-
Dova Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Operating and Financial Results
-
-
-
-
-
-
-
Dova Pharmaceuticals Announces the Appointment of Mark W. Hahn as Chief Financial Officer
-
-
-
-
-
-
-
Dova Pharmaceuticals Announces FDA Acceptance of the Avatrombopag New Drug Application (NDA) with Priority Review
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

